http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-PA05012309-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9259cfa966fe620251340a003f5d6125 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-16 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-16 |
filingDate | 2004-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d434e80a6ba3ae8c2623e560bb578da |
publicationDate | 2006-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | MX-PA05012309-A |
titleOfInvention | METHODS TO PREPARE DERIVATIVES OF 2-ALQUINYLADENOSINE. |
abstract | Methods for preparing 2-alkyladenosine derivatives of Formula (A) are described: (see formula A) or a stereoisomer, salt, hydrate, solvate, acid salt hydrate, or pharmaceutically acceptable isoformic crystalline form thereof, the method comprises step of contacting 2-iodoadenosine-5 ° -N-ethyluronamide with a compound of Formula (B): (see formula B) where Z is -C (= O) OR or -CH2OC (= O) R, where R is a C1 to C5 alkyl, preferably methyl. The methods are useful for preparing 2-alkyladenosine derivatives that are, in certain embodiments, adenosine receptor agonists. |
priorityDate | 2003-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Predicate | Subject |
---|---|
isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636 |
Total number of triples: 13.